Spots Global Cancer Trial Database for stage iv prostate adenocarcinoma ajcc v7
Every month we try and update this database with for stage iv prostate adenocarcinoma ajcc v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy | NCT02099864 | Castration-Resi... Metastatic Mali... Metastatic Mali... Metastatic Pros... Recurrent Prost... Stage III Prost... Stage IV Prosta... | Enzalutamide | 18 Years - | OHSU Knight Cancer Institute | |
| Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis | NCT01409200 | Metastatic Mali... Prostate Ductal... Stage III Prost... Stage IV Prosta... | Antiandrogen Th... Axitinib Radical Prostat... Regional Lymph ... | 18 Years - | M.D. Anderson Cancer Center | |
| Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer | NCT02893917 | Advanced Prosta... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Adenoc... Stage IV Prosta... | Cediranib Olaparib | 18 Years - | National Cancer Institute (NCI) | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency | NCT03442556 | ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Castration Leve... Castration-Resi... Homologous Reco... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... | Carboplatin Docetaxel Laboratory Biom... Rucaparib Camsy... Rucaparib | 18 Years - | University of Washington | |
| Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer | NCT02215161 | Castration Leve... Hormone-Resista... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... | Selinexor | 18 Years - | University of California, San Francisco | |
| ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer | NCT03456804 | Castration Leve... Castration-Resi... Metastatic Pros... PSA Progression Stage IV Prosta... | ESK981 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer | NCT03503344 | Castration Leve... Castration-Resi... PSA Progression Stage IV Prosta... | Apalutamide Stereotactic Bo... | 18 Years - | University of California, San Francisco | |
| Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03406858 | Castration Leve... Castration-Resi... Prostate Carcin... PSA Progression Stage IV Prosta... | HER2Bi-Armed Ac... Laboratory Biom... Pembrolizumab | 19 Years - | Barbara Ann Karmanos Cancer Institute | |
| Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer | NCT03406858 | Castration Leve... Castration-Resi... Prostate Carcin... PSA Progression Stage IV Prosta... | HER2Bi-Armed Ac... Laboratory Biom... Pembrolizumab | 19 Years - | Barbara Ann Karmanos Cancer Institute | |
| Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer | NCT03503344 | Castration Leve... Castration-Resi... PSA Progression Stage IV Prosta... | Apalutamide Stereotactic Bo... | 18 Years - | University of California, San Francisco | |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT03361735 | Prostate Adenoc... | Leuprolide Acet... Goserelin Aceta... Stereotactic Bo... Radium Ra 223 D... Laboratory Biom... Degarelix | 18 Years - | City of Hope Medical Center | |
| Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | NCT00544830 | PSA Level Great... Stage IV Prosta... | Bicalutamide Goserelin Aceta... Intensity-Modul... Laboratory Biom... Leuprolide Acet... | 18 Years - | City of Hope Medical Center | |
| ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer | NCT03456804 | Castration Leve... Castration-Resi... Metastatic Pros... PSA Progression Stage IV Prosta... | ESK981 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer | NCT03456804 | Castration Leve... Castration-Resi... Metastatic Pros... PSA Progression Stage IV Prosta... | ESK981 | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer | NCT03456843 | Stage IV Prosta... | Antiandrogen Th... Docetaxel Laboratory Biom... Quality-of-Life... Questionnaire A... Radical Prostat... | 18 Years - | Yale University | |
| Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer | NCT03456843 | Stage IV Prosta... | Antiandrogen Th... Docetaxel Laboratory Biom... Quality-of-Life... Questionnaire A... Radical Prostat... | 18 Years - | Yale University | |
| ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer | NCT03456804 | Castration Leve... Castration-Resi... Metastatic Pros... PSA Progression Stage IV Prosta... | ESK981 | 18 Years - | Barbara Ann Karmanos Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
